SCYNEXIS, Inc. (SCYX) Company Bio

SCYNEXIS, Inc., a pharmaceutical company, develops and commercializes novel anti-infectives to address unmet therapeutic needs. Its lead product candidate includes SCY-078, which is in Phase I clinical trials of the intravenous formulation; Phase II clinical trials for the treatment of invasive candida infections; and Phase II clinical trials for unmet medical needs, such as vulvovaginal candidiasis. The company was founded in 1999 and is based in Jersey City, New Jersey.

SCYX Daily Price Range
SCYX 52-Week Price Range
Add SCYX to Watchlist
Sign Up

SCYX - Live POWR Rating™

Overall POWR Rating

To view SCYX's real-time POWR Rating, sign up now.

Access Ratings for Free

SCYX News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All SCYX News
The Top Stocks For 2019

SCYX Stock Chart More Charts

SCYX Price/Volume Stats

Current price $1.38
Prev. close $1.37
Day low $1.34
Day high $1.40
50-day MA $0.76
200-day MA $1.21
52-week high $2.15
52-week low $0.35
Volume 494,259
Avg. volume 1,864,053
Dividend yield N/A
Market Cap 66.20M

SCYX Social Stream

Loading social stream, please wait...

View Full SCYX Social Stream

SCYX Returns

1-mo 72.50%
3-mo 70.37%
6-mo 0.73%
1-year -22.03%
3-year -70.76%
5-year N/A
YTD 187.50%
2018 -79.31%
2017 -27.27%
2016 -48.63%
2015 -37.78%
2014 N/A
Page generated in 0.2915 seconds.